EWTX
NASDAQ · Pharmaceuticals
Edgewise Therapeutics Inc
$36.50
-0.31 (-0.84%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+38.52%
1Y
+157.40%
YTD
+53.68%
Open$37.51
Previous Close$36.81
Day High$37.51
Day Low$35.96
52W High$40.77
52W Low$12.15
Volume—
Avg Volume2.13M
Market Cap3.96B
P/E Ratio—
EPS$-1.66
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$26.49
Above
SMA 200
$18.41
Above
RSI (14)
53.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
+93.0% upside
Current
$36.50
$36.50
Target
$70.44
$70.44
$45.77
$70.44 avg
$86.30
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 407.17M | 429.50M | 324.39M |
| Net Income | 72.15M | 91.13M | 54.38M |
| Profit Margin | 17.7% | 21.2% | 16.8% |
| EBITDA | 147.48M | 172.82M | 113.17M |
| Free Cash Flow | 69.60M | 65.40M | 42.96M |
| Rev Growth | +16.1% | +0.2% | +22.1% |
| Debt/Equity | 0.29 | 0.25 | 0.27 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,108.83 | +0.61% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $238.07 | +2.93% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.15 | +3.18% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.91 | -0.68% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.90 | +2.19% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.92 | +1.36% | 12.5 | 33.00B |